个人简介
1983年毕业于上海医科大学获临床医学学士学位,1993年获上海医科大学临床医学硕士学位,2002年晋升为主任医师。从事头颈部肿瘤外科33年,擅长于甲状腺癌、喉癌、下咽癌及舌癌的临床及基础研究。现任复旦大学附属肿瘤医院头颈部肿瘤多学科综合治疗组首席专家、中国抗癌协会甲状腺癌专业委员会副主任委员、中国医师协会甲状腺癌专业委员会副主任委员、上海抗癌协会甲状腺癌专业委员会主任委员、上海医学会普外科专业委员会甲状腺学组组长、中国抗癌协会头颈肿瘤专业委员会常委、上海抗癌协会头颈肿瘤专业委员会前任主任委员、意大利内分泌外科协会荣誉会员,担任《中华耳鼻咽喉---头颈外科杂志》、《中华外科杂志》、《中华肿瘤杂志》、《中国医学科学院学报》、《肿瘤》、《中国癌症杂志》、《Chinese Medical Journal》、《Medicine》、《World Journal of Surgical Oncology》及《Oncotargets and Therapy》杂志编委及审稿专家。主持国家科学基金面上项目五项、上海市科委重大项目、上海市基础研究重大项目及上海市重中之重项目多项,参与编写《肿瘤外科手术学》,沈镇宙主编,江苏科学技术出版社;《现代肿瘤学》,汤钊猷主编,复旦大学出版社;《外科学》七年制教材,陈孝平主编,人民卫生出版社;《口腔颌面头颈部肿瘤生物学》,陈万涛主编,上海交通大学出版社;发表论文50余篇,其中SCI收录30余篇,国内权威期刊10余篇。
近期论文
查看导师最新文章
(温馨提示:请注意重名现象,建议点开原文通过作者单位确认)
Litao Han#, Hejing Lai#, Yichen Yang#, Jiaqian Hu#, Zhe Li, Ben Ma, Weibo Xu, Wanlin Liu, Wenjun Wei, Duanshu Li, Yu Wang*, Qiwei Zhai*, Qinghai Ji* and Tian Liao*. A 5'-tRNA halve, tiRNA-Gly promotes cell proliferation and migration via binding to RBM17 and inducing alternative splicing in papillary thyroid cancer. J Exp Clin Cancer Res. 2021 Jul 05;40(1): 222.
Qu N#, Shi X#, Zhao JJ#, Guan H, Zhang TT, Wen SS, Liao T, Hu JQ, Liu WY, Wang YL, Huang S, Shi RL*, Wang Y*, Ji QH*. Genomic and Transcriptomic Characterization of Sporadic Medullary Thyroid Carcinoma. Thyroid. 2020 Jul; 30(7):1025-1036.
Shi X#, Yu PC#, Lei BW#, Li CW, Zhang Y, Tan LC, Shi RL, Wang J, Ma B, Xu WB, Wang X, Hu JQ, Huang NS, Wei WJ, Wang Y, Chen TZ, Wang YL*, Ji QH*. Association Between Programmed Death-Ligand 1 Expression and Clinicopathological Characteristics, Structural Recurrence, and Biochemical Recurrence/Persistent Disease in Medullary Thyroid Carcinoma. Thyroid, 2019 Sep; 29(9):1269-1278.
Ma B#, Jiang H#, Wen D, Hu J, Han L, Liu W, Xu W, Shi X, Wei W, Liao T, Wang Y, Lu Z, Wang Y*, Ji QH*. Transcriptome analyses identify a metabolic gene signature indicative of dedifferentiation of papillary thyroid cancer. J Clin Endocrinol Metab, 2019 Sep 1; 104(9):3713-3725.
Ma B#, Wei W#, Xu W#, Wang Y, Guan H, Fan J, Zhao Z, Wen D, Yang S, Wang Y*, Chang B*, Ji QH*. Surgical Confirmation of Incomplete Treatment for Primary Papillary Thyroid Carcinoma by Percutaneous Thermal Ablation: A Retrospective Case Review and Literature Review. Thyroid, 2018 Sep; 28(9):1134-1142.
Shi X#, Huang NS#, Lei BW#, Song KH, Shi RL, Wei WJ, Hu WP, Dong F, Wang Y, Wang YL*, Ji QH*. Central Lymph Node Status has Significant Prognostic Value in the Clinically Node-Negative Tall-Cell Variant of Papillary Thyroid Cancer Regardless of T-Staging and Radioactive Iodine Administration: First Evidence From a Population-Based Study. Ann Surg Oncol, 2018 Aug; 25(8):2316-2322.
Shi X#, Dong F#, Wei W#, Song K, Huang N, Lu Z, Lei B, Yu P, Liu W, Wang Y, Sun G, Wang Y, Ji Q*. Prognostic significance and optimal candidates of primary tumor resection in major salivary gland carcinoma patients with distant metastases at initial presentation: A population-based study. Oral Oncol, 2018 Mar; 78: 87-93.
Shi RL#, Qu N#, Luo TX#, Xiang J, Liao T, Sun GH, Wang Y, Wang YL*, Huang CP*, Ji QH*. Programmed Death-Ligand 1 Expression in Papillary Thyroid Cancer and Its Correlation with Clinicopathologic Factors and Recurrence. Thyroid, 2017 Apr; 27(4):537-545.
Wang YL#, Feng SH#, Guo SC#, Wei WJ, Li DS, Wang Y, Wang XF, Wang ZY, MaYY, JinL, Ji QH,Wang JC*. Confirmation of papillary thyroid cancer susceptibility loci identified by genome-wide association studies of chromosomes 14q13, 9q22, 2q35and 8p12 in a Chinese population. J Med Genet, 2013 Oct; 50(10):689-95.
Zhang L#, Wei WJ#, Ji QH, Zhu YX, Wang ZY, Wang Y, Huang CP, Shen Q, Li DS, Wu Y.Risk factors for neck nodal metastasis in papillary thyroid microcarcinoma: a study of 1066 patients. J Clin Endocrinol Metab, 2012 Apr; 97(4):1250-7.